COBRA-OS® Ordering Information for Military – Please click here.

Front Line Medical Technologies Wins Medical Device/Technology Company of the Year at the 2025 Canadian Healthcare Industry Awards

Prestigious recognition underscores the company’s commitment to advancing life-saving medical innovations and improving patient outcomes across Canada

LONDON, ON, January 23, 2025Front Line Medical Technologies, a leader in innovative medical devices for emergency and trauma care, is proud to announce that it has been recognized as the Medical Device/Technology Company of the Year at the prestigious 2025 Canadian Healthcare Industry Awards (CHIAs). This award highlights the company’s ongoing commitment to advancing life-saving medical innovations and improving patient outcomes across Canada.

The CHIAs celebrate excellence in the life sciences industry, honoring organizations and individuals who have made significant contributions to healthcare innovation. Winners were selected by an independent panel of esteemed healthcare professionals, recognizing companies that have demonstrated leadership, ingenuity, and impact in their respective fields.

“We are incredibly honored to receive this recognition,” said Dr. Asha Parekh, CEO at Front Line Medical Technologies. “Our team is deeply committed to developing medical technologies that make a tangible difference in patient care. This award is a testament to our dedication to pushing the boundaries of innovation and improving emergency and critical care solutions.”

Front Line Medical Technologies has consistently focused on designing and delivering advanced medical solutions that address critical challenges in healthcare. The company’s groundbreaking technologies have played a vital role in enhancing patient care, streamlining medical procedures, and supporting healthcare providers in delivering effective treatment.

Front Line Medical Technologies extends its gratitude to the CHIA organizers, the esteemed panel of judges, and the broader medical community for this recognition. The company remains dedicated to its mission of advancing medical technology and improving healthcare systems to impact patient lives positively.

“This recognition reinforces our mission to create medical technologies that are not only innovative but also practical and effective in high-pressure situations,” said Seema Gogna, Director of Products at Front Line Medical Technologies. “We remain focused on delivering solutions that empower healthcare providers and ultimately improve patient outcomes.”

Healthcare providers can learn more about the COBRA-OS® or schedule a personalized demonstration by visiting www.frontlinemedtech.com.

About Front Line Medical Technologies 

Front Line Medical Technologies is driven by a singular mission, helping critical patients survive. The company goes beyond traditional medical device development, committing itself to transforming emergency care through innovative solutions that prioritize both effectiveness and simplicity. Operating at the forefront of emergency circulatory support, the company has developed the COBRA-OS® (Control of Bleeding, Resuscitation, Arterial Occlusion System) – the smallest life-saving aortic occlusion device available. At just 4 French, this innovative technology represents a breakthrough in hemorrhage control, designed to buy precious time when every second counts.

Share:

Facebook
Twitter
LinkedIn
On Key

Related Posts

Clinician performing an endovascular procedure during prolonged partial REBOA, with patient monitoring and an elapsed-time clock visible.

Before We Extend the Clock: A Cautious Look at Prolonged Partial REBOA

Partial REBOA may offer advantages over complete aortic occlusion, but extending occlusion time raises important questions about patient selection, transport, monitoring and delays to definitive hemorrhage control. This article examines why stronger human evidence is needed before prolonged partial REBOA becomes routine practice.

Doctor meeting with a medical technology developer discussing AI-powered MedTech innovation beside a digital interface displaying robotic surgical technology.

Speed Is Not Wisdom: MedTech Innovation in the Age of AI

Aortic occlusion has traditionally been viewed as a rescue intervention for severe hemorrhage. New evidence suggests low-profile systems may support a broader role, helping clinicians proactively manage predictable bleeding in selected surgical and trauma cases.